Form 4: IN8BIO CFO Acquires Stock Options in Recent Transaction

Patrick McCall, CFO of IN8BIO, Inc., reports the acquisition of stock options in a transaction dated December 19, 2024.

Summary

• Patrick McCall, the Chief Financial Officer of IN8BIO, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on December 19, 2024.
• McCall acquired 290,085 employee stock options with an exercise price of $0.24.
• These options vest on December 19, 2025, contingent upon continued service.
• The options expire on December 19, 2034.
• Following the reported transaction, McCall directly owns 290,085 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to a company executive. The grant itself can be seen as a positive, but the filing is simply a factual report.

Positives

• The acquisition of stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC filing related to insider transactions. It's common for executives to receive stock options as part of their compensation packages, aligning their interests with those of shareholders.

Stakeholder Impact

• The acquisition of stock options by the CFO could potentially impact shareholder sentiment, depending on how investors interpret the transaction.

Key Dates